The legal and administrative systems used to manage the classification, production, distribution, prescribing, and availability of controlled substances. These regulatory frameworks aim to ensure that substances with psychoactive properties are safely produced, distributed, and used for legitimate medical and scientific purposes, while preventing diversion, misuse, and illegal distribution. Regulatory control may include drug scheduling, licensing of manufacturers and prescribers, prescription monitoring systems, import and export controls, and pharmaceutical supply oversight. These mechanisms help balance access to essential medicines with the protection of public health and safety.
Regulatory Control of Substances
Drug production and precursors — EUDA ongoing activities
Highlights from the 2026 UNODC World Drug Report
2025 National Drug Threat Assessment (NDTA) - Drug Enforcement Administration (DEA)
NEW Security Document Examination module in the UN Toolkit on Synthetic Drugs
EU controls nine drug precursors following first EUDA assessments
Leveraging National Surveillance Networks for Local Action and Collective Impact
Featuring: Dr. Samantha King, CCSA Research and Policy Analyst
NordAN 2026: Public health, policy and prevention in changing times
NordAN 2026 brings together policymakers, researchers, and civil society actors from across the Nordic and Baltic region to discuss current developments in alcohol policy and public health. At a time when long-standing policy frameworks are being challenged, the conference provides a space to exchange experiences, compare national developments, and reflect on future directions.
Alcohol Law & Policy Conference 2026
Each year, the Center brings together some of the best minds in the country – including state alcohol regulators, public health leaders, state attorneys general, state legislators, educators, and industry members – to discuss and debate current alcohol issues and challenges. The conference has become the leading national forum for alcohol policy education and networking.
Ketamine in Europe
Objective: This webinar aims to provide insights into the European ketamine market and will expand on health-related harms caused by non-medical ketamine use.
2026 National Drug Control Strategy - The White House